Chlamydia and gonorrhea are the most prevalent, treatable STDs*. If left untreated, complications can include infertility, pelvic inflammatory disease, pregnancy complications.2,3
ECDC recommends:
Routine screening of Chlamydia and gonorrhea on an annual basis is recommended for all sexually active females aged <25 years1
Chlamydia and gonorrhea screening have been extended to young men in some countries
NAATs^ are the recommended diagnosis for chlamydia and gonorrhea4
Same-day testing and treatment
BHIVA/BASHH recommends:
Full STI screen at baseline including NAAT^ testing for gonococcal and chlamydial infections at sites of exposure (genital, rectal, pharyngeal) and syphilis serology
3-monthly screening for bacterial STIs (chlamydia, gonorrhoea and syphilis) for individuals receiving PrEP#, especially for MSM and transwomen
The Solution
Accurate on-demand RT-PCR results are ready when you need them
On-demand and in-visit results reduce patient call-backs, overtreatment, undertreatment and patients lost to follow-up
Patient collected specimens can create operational efficiencies
Same patient sample can be utilized for all tests
The Impact
Provide fast patient results to:
Reduce patient anxiety with immediate results
Improve patient satisfaction
Prevent disease spread in the community
Reduce unnecessary use of antibiotics
Impact on Patient Pathway
Improving Patient Satisfaction
Xpert® CT/NG provides medically actionable information to clinicians enabling same-day treatment for chlamydia and gonorrhea.